Hepatic focal nodular hyperplasia during follow-up of patients after cyclophosphamide- or oxaliplatin-based chemotherapy: differentiation from liver metastasis
Cancer survivors, after chemotherapy, can develop hepatic focal nodular hyperplasia. Cyclophosphamide and oxaliplatin are two chemotherapeutic agents that predispose to focal nodular hyperplasia development. Focal nodular hyperplasia occurs at shorter intervals in patients treated with cyclophosphamide.
Authors
- Rui Zhao (ORCID: https://orcid.org/0000-0003-2062-5385)
- Hongmei Zhang (ORCID: https://orcid.org/0000-0002-6421-4126)
- Xiangchun Liu (ORCID: https://orcid.org/0000-0001-5822-6094)
- Shuang Chen (ORCID: https://orcid.org/0000-0001-6716-1763)
- Feng Ye (ORCID: https://orcid.org/0000-0001-9513-4308)
- Lijuan Wan
- Fan Yang (ORCID: https://orcid.org/0000-0002-8111-4880)
- Wenjing Peng (ORCID: https://orcid.org/0000-0002-5151-9545)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- Insights into Imaging
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s13244-024-01793-7
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00